Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Director/PDMR Shareholding

19 Mar 2007 15:22

TR-1 (i) NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

Lidco Group Plc

2. Reason for the notification State Yes/No An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): Transparency Obligations Yes Directive

3. Full name of person(s) subject to the notification Terence O'Brien obligation (iii):

4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 6. Date on which issuer notified: 19.03.07 7. Threshold(s) that is/are crossed or reached: 8. Notified details:

A: Voting rights attached to shares

Class/type of Situation Resulting situation after the triggering shares previous to transaction (vii) if possible the Triggering using the ISIN transaction (vi) CODE Number Number Number Number of voting % of voting of of of rights (ix) rights Shares Voting shares Rights (viii) Direct Direct Indirect Direct Indirect (x) (xi) GB0030546849 10,109,577 10,109,577 8.54 B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of Expiration Exercise/ Number of voting % of financial date (xiii) Conversion rights that may be voting instrument Period/ Date (xiv) acquired if the rights instrument is exercised/ converted Total (A+B) Number of voting rights % of voting rights 10,109,577 8.54

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

Proxy Voting:10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting

rights: 13. Additional information: 14. Contact name: R Lamb

15. Contact telephone number: 0207 749 1521

Annex Notification Of Major Interests In Shares (xvi)

A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities) Contact address (registered office for legal entities) Phone number Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable (xvii)

Full name Contact address Phone number

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional informationNotes

i. This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

ii. Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

iii. This should be the full name of (a) the shareholder; (b) the person acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to in DTR5.2.1 (a), or (d) the direct or indirect holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, as appropriate.

In relation to the transactions referred to in points DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

- in the circumstances foreseen in DTR5.2.1 (b), the person that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

- in the circumstances foreseen in DTR 5.2.1 (c), the person holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and person lodging the collateral under these conditions;

- in the circumstances foreseen in DTR5.2.1(d), the person who has a life interest in shares if that person is entitled to exercise the voting rights attached to the shares and the person who is disposing of the voting rights when the life interest is created;

- in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

- in the circumstances foreseen in DTR5.2.1 (g), the person that controls the voting rights;

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

iv. Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This should be the full name of the shareholder or holder of financial instruments who is the counterparty to the natural person or legal entity referred to in DTR5.2.

v. The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, date of the entering into an agreement.

The date on which threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect (see DTR 5.1.1R (3)). For passive crossings, the date when the corporate event took effect.

These dates will usually be the same unless the transaction is subject to a condition beyond the control of the parties.

vi. Please refer to the situation disclosed in the previous notification, In case the situation previous to the triggering transaction was below 3%, please state `below 3%'.

vii. If the holding has fallen below the minimum threshold , the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is less than 3%.

For the case provided for in DTR5.2.1(a), there should be no disclosure of individual holdings per party to the agreement unless a party individually crosses or reaches an Article 9 threshold. This applies upon entering into, introducing changes to or terminating an agreement.

viii. Direct and indirect

ix In case of combined holdings of shares with voting rights attached `direct holding' and voting rights `indirect holdings', please split the voting rights number and percentage into the direct and indirect columns-if there is no combined holdings, please leave the relevant box blank.

x Voting rights attached to shares in respect of which the notifying party is a direct shareholder (DTR 5.1)

xi. Voting rights held by the notifying party as an indirect shareholder (DTR 5.2.1)

xii If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

xiii date of maturity / expiration of the finical instrument i.e. the date when the right to acquire shares ends.

xiv If the financial instrument has such a period-please specify the period- for example once every three months starting from the [date]

xv. The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

xvi. This annex is only to be filed with the competent authority.

xvii. Whenever another person makes the notification on behalf of the shareholder or the natural person/legal entity referred to in DTR5.2 and DTR5.3.

LIDCO GROUP PLC
Date   Source Headline
29th Mar 20167:00 amRNSRegulatory approval in China
24th Mar 20167:00 amRNSMaster distribution agreement & other distributors
15th Mar 20167:00 amRNSLaunching the new LiDCOunity at ISICEM Brussels
4th Mar 20164:31 pmRNSHolding(s) in Company
2nd Mar 20165:06 pmRNSBlock Listing Review
8th Feb 20167:00 amRNSTrading update
2nd Feb 20163:52 pmRNSHolding(s) in Company
23rd Nov 20157:00 amRNSMaster distribution agreement
16th Nov 20154:35 pmRNSDirector's Dealing
13th Oct 20158:30 amRNSUS purchasing agreement with US hospitals group
13th Oct 20157:00 amRNSHalf Yearly Report
23rd Sep 201510:03 amRNSNotice of Results
2nd Sep 20157:00 amRNSTrading update and notice of results
17th Aug 20157:00 amRNSFormal appointment of Chief Executive Officer
31st Jul 20157:00 amRNSBlock Listing Review
15th Jun 20152:27 pmRNSBoard appointment and grant of share options
11th Jun 20157:00 amRNSJapan reimbursement for LiDCOrapidv2 disposables
13th May 201511:45 amRNSResult of AGM
6th May 20157:01 amRNSCEO and Board Appointment
5th May 20151:32 pmRNSPosting of Annual Report & Notice of AGM
23rd Apr 20157:00 amRNSLiDCO data presented at London Forum
14th Apr 20157:00 amRNSHolding in Company
1st Apr 201512:49 pmRNSDirector/PDMR Shareholding
31st Mar 20157:01 amRNSLIDCOrapid v2 cleared for sale in Japan
31st Mar 20157:00 amRNSFinal Results
17th Mar 20157:00 amRNSShowcasing Portable LiDCO Stand System at ISICEM
10th Mar 20157:03 amRNSNotice of Results
2nd Mar 20156:14 pmRNSHolding(s) in Company
17th Feb 20157:00 amRNSFurther clinical support for LiDCOrapid
12th Feb 20157:00 amRNSTrading update and notice of results
30th Jan 201512:20 pmRNSBlock listing review
17th Dec 20142:39 pmRNSHolding(s) in Company
1st Dec 20142:39 pmRNSHolding(s) in Company
17th Nov 20147:00 amRNSFurther clinical support for LiDCOrapid
12th Nov 20145:15 pmRNSHolding(s) in Company
7th Nov 201412:03 pmRNSHolding(s) in Company
3rd Nov 20145:49 pmRNSHolding(s) in Company
16th Sep 20147:01 amRNSBoard Announcement
16th Sep 20147:00 amRNSHalf Yearly Report
21st Aug 201411:39 amRNSNotice of Results
18th Aug 20147:00 amRNSTrading update
31st Jul 20141:46 pmRNSBlock Listing Review
30th Jul 20147:00 amRNSFurther clinical support for LiDCO products
11th Jun 201412:45 pmRNSResult of AGM
11th Jun 201411:49 amRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
23rd May 20141:51 pmRNSPosting of Annual Report & Notice of AGM
22nd May 20144:01 pmRNSHolding(s) in Company
21st May 20147:00 amRNSMonitors Link with NantHealth's DeviceConX System
20th May 20147:00 amRNSResults of the OPTIMISE study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.